Correlation Between Candel Therapeutics and Lifecore Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Lifecore Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Lifecore Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Lifecore Biomedical, you can compare the effects of market volatilities on Candel Therapeutics and Lifecore Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Lifecore Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Lifecore Biomedical.

Diversification Opportunities for Candel Therapeutics and Lifecore Biomedical

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Candel and Lifecore is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Lifecore Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifecore Biomedical and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Lifecore Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifecore Biomedical has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Lifecore Biomedical go up and down completely randomly.

Pair Corralation between Candel Therapeutics and Lifecore Biomedical

Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Lifecore Biomedical. In addition to that, Candel Therapeutics is 1.66 times more volatile than Lifecore Biomedical. It trades about -0.04 of its total potential returns per unit of risk. Lifecore Biomedical is currently generating about -0.01 per unit of volatility. If you would invest  742.00  in Lifecore Biomedical on December 29, 2024 and sell it today you would lose (57.00) from holding Lifecore Biomedical or give up 7.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Candel Therapeutics  vs.  Lifecore Biomedical

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Candel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Lifecore Biomedical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lifecore Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Lifecore Biomedical is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Candel Therapeutics and Lifecore Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and Lifecore Biomedical

The main advantage of trading using opposite Candel Therapeutics and Lifecore Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Lifecore Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will offset losses from the drop in Lifecore Biomedical's long position.
The idea behind Candel Therapeutics and Lifecore Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world